Press "Enter" to skip to content

New patent for Astrazeneca drug TUDORZA PRESSAIR

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug TUDORZA PRESSAIR

Annual Drug Patent Expirations for TUDORZA+PRESSAIR
Annual Drug Patent Expirations for TUDORZA+PRESSAIR

Tudorza Pressair is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has one hundred and twenty-seven patent family members in forty-three countries.

The generic ingredient in TUDORZA PRESSAIR is aclidinium bromide. One supplier is listed for this compound. Additional details are available on the aclidinium bromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug TUDORZA PRESSAIR
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions